21st Austria weekly - Valneva, EVN (25/02/2022)

21st Austria weekly - Valneva EVN 25/02/2022 [pic1]Valneva: Valneva SE an Austrian/French specialty vaccine company today announced that the Committee for Medicinal Products Human Use CHMP of European Medicines Agency EMA has provided initial assessment Valneva’s inactivated adjuvanted COVID-19

Related Keywords

Austria ,Austrian , ,European Medicines Agency ,Committee For Medicinal Products Human Use ,Medicinal Products ,Human Use ,South East Europe ,Besuchen Sie ,Ic1 Valneva ,Valneva ,Tse ,Austrian French ,Committee ,Medicinal ,Products ,Human ,Use ,Chmp ,European ,Medicines ,Agency ,Fema ,Valneva Amp Rsquo S ,Covid 19 ,